Skip to content
S1742Senate2021-2022 SessionSame asA1534

Let Pharmacists Test Diseases

Official title

“Relates to allowing for the testing of certain infectious diseases by pharmacists during a state of emergency”

Sponsor James SkoufisSD-39+3 co-sponsorsAffects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill allows pharmacists to conduct FDA-approved infectious disease testing at pharmacies during a declared state of emergency.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Let Pharmacists Test Diseases

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 39

Chair, Investigations And Government Operations

History

  1. Referred to health
  2. Committed to rules
  3. Advanced to third reading
  4. 2nd report cal.
  5. 1st report cal.540
  6. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A1534Assembly

Let Pharmacists Test Diseases

In Assembly Committee · Higher Education · Sponsor Richard Gottfried

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1742

2021-2022 Regular Sessions

IN SENATE

January 14, 2021

Introduced by Sens. SKOUFIS, ADDABBO, HOYLMAN, LIU -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to allowing for the testing of certain infectious diseases at pharmacies

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 579 of the public health law is amended by adding a new subdivision 4 to read as follows:

4. (a) This title shall not be applicable in a declared state of emergency, pursuant to section twenty-eight of the executive law, to any licensed pharmacists ordering infectious disease tests, approved by the food and drug administration, to detect the infectious disease or its antibodies, and administering such tests, subject to certificate of waiver requirements pursuant to the federal clinical laboratory improvement act of nineteen hundred eighty-eight, to patients suspected of an infectious disease, or suspected of having recovered from an infectious disease, subject to completion of appropriate training developed by the department.

(b) In a declared state of emergency, pursuant to section twenty-eight of the executive law, licensed pharmacists shall be designated as a qualified healthcare professional for the purpose of directing a limited service laboratory, pursuant to subdivision three of this section, to test patients suspected of an infectious disease or its antibodies provided that such test is approved by the food and drug administration and waived for its use in a limited service laboratory.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00593-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to allowing for the testing of certain infectious diseases at pharmacies

Purpose

To permit licensed pharmacists to order and administer infectious diseases tests approved by the FDA in a declared state of emergency.

Summary of provisions

Section 1: Amends Section 579 of the Public Health Law by adding subdi- vision 4, to permit licensed pharmacists, during a declared state of emergency, to order and administer tests to patients suspected of an infectious disease or its antibodies, provided such test is approved by the Food and Drug Administration (FDA). Requires certification of waiver requirements pursuant to the Federal Clinical Laboratory Improvement Act of 1988 and requires such pharmacists complete appropriate training developed by the FDA. Designates licensed pharmacists as qualified healthcare professionals for the purpose of directing a limited service laboratory, for the purpose of testing patients, provided such test is approved by the FDA and waived for its use in a limited service labora- tory.

Section 2: Effective date.

Justification

As was evident with the initial spread of COVID-19 in New York State, the demands placed upon hospitals and healthcare providers are often overwhelming. Permitting licensed pharmacists to order and administer such tests will lessen the burden placed on our hospitals by freeing up physicians, nurses and other healthcare providers to actively provide patient care, allowing for the more efficient treatment of patients. The bill will codify temporary provisions included in Executive Order No.202.24.

Legislative history

2020 - S8570 Referred to Rules

Assembly

2020 - A10699 Referred to Higher Education

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.